Dupont Capital Management Corp Eli Lilly & CO Transaction History

Dupont Capital Management Corp

$1.18 Billion
Q3 2024

A detailed history of Dupont Capital Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Dupont Capital Management Corp holds 18,644 shares of LLY stock, worth $14.8 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares

18,644

Previous 25,289 26.28%

Holding current value

$14.8 Million

Previous $22.9 Million 27.86%

% of portfolio

1.4%

Previous 2.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$772.14 - $960.02 $5.13 Million - $6.38 Million	-6,645 Reduced 26.28%	18,644 $16.5 Million
Q4 2023 Jan 23, 2024	SELL	$525.19 - $619.13 $10.3 Million - $12.2 Million	-19,692 Reduced 43.78%	25,289 $14.7 Million
Q3 2023 Oct 27, 2023	BUY	$434.7 - $599.3 $8.64 Million - $11.9 Million	19,885 Added 79.24%	44,981 $24.2 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $1.76 Million - $2.35 Million	5,008 Added 24.93%	25,096 $11.8 Million
Q1 2023 Apr 28, 2023	BUY	$310.63 - $364.82 $989,045 - $1.16 Million	3,184 Added 18.84%	20,088 $6.9 Million
Q4 2022 Jan 26, 2023	BUY	$321.55 - $374.67 $251,452 - $292,991	782 Added 4.85%	16,904 $0
Q3 2022 Oct 31, 2022	SELL	$296.48 - $337.87 $4.15 Million - $4.73 Million	-13,988 Reduced 46.46%	16,122 $5.21 Million
Q2 2022 Jul 26, 2022	SELL	$278.73 - $327.27 $542,687 - $637,194	-1,947 Reduced 6.07%	30,110 $9.76 Million
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $1.26 Million - $1.56 Million	5,359 Added 20.07%	32,057 $9.18 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $3.6 Million - $4.47 Million	16,025 Added 150.15%	26,698 $7.38 Million
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $714,216 - $878,944	-3,223 Reduced 23.19%	10,673 $2.47 Million
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $64,456 - $83,373	357 Added 2.64%	13,896 $3.19 Million
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $682,420 - $883,426	-4,153 Reduced 23.47%	13,539 $2.53 Million
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $406,121 - $537,397	-3,113 Reduced 14.96%	17,692 $2.99 Million
Q3 2020 Oct 29, 2020	SELL	$146.22 - $169.13 $2.68 Million - $3.1 Million	-18,317 Reduced 46.82%	20,805 $3.08 Million
Q2 2020 Jul 24, 2020	SELL	$136.42 - $164.18 $1.47 Million - $1.77 Million	-10,781 Reduced 21.6%	39,122 $6.42 Million
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $3.87 Million - $4.79 Million	32,533 Added 187.29%	49,903 $6.92 Million
Q4 2019 Jan 27, 2020	SELL	$106.92 - $132.43 $2.55 Million - $3.16 Million	-23,863 Reduced 57.87%	17,370 $2.28 Million
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $602,082 - $654,910	-5,638 Reduced 12.03%	41,233 $4.61 Million
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $2.53 Million - $2.95 Million	-22,812 Reduced 32.74%	46,871 $5.19 Million
Q1 2019 Apr 30, 2019	SELL	$111.31 - $131.02 $540,521 - $636,233	-4,856 Reduced 6.51%	69,683 $9.04 Million
Q4 2018 Feb 01, 2019	BUY	$105.9 - $118.64 $423,176 - $474,085	3,996 Added 5.66%	74,539 $8.63 Million
Q3 2018 Nov 05, 2018	SELL	$85.86 - $107.31 $328,929 - $411,104	-3,831 Reduced 5.15%	70,543 $7.57 Million
Q2 2018 Jul 30, 2018	BUY	$75.7 - $86.88 $44,057 - $50,564	582 Added 0.79%	74,374 $6.35 Million
Q1 2018 May 02, 2018	BUY	$74.21 - $87.6 $1.81 Million - $2.14 Million	24,434 Added 49.5%	73,792 $5.71 Million
Q4 2017 Jan 31, 2018	SELL	$81.94 - $87.89 $4.41 Million - $4.73 Million	-53,790 Reduced 52.15%	49,358 $4.17 Million
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $7.95 Million - $8.82 Million	103,148	103,148 $8.82 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account

Dupont Capital Management Corp Eli Lilly & CO Transaction History